Featured
Want to learn more about Pharmacovigilance and Risk Management Strategies Conference? You've come to the right site!
プログラム委員会
-
Stella Blackburn, MD, MA, MSC, FFPM, FISPE, FRCP Strategy
Consultant, United Kingdom -
James Wabby, MHS Global Head, Regulatory Affairs, Emerging Technologies and Combination Products
AbbVie, United States -
Mariette Boerstoel-Streefland, MD, MBA, MS Senior Vice President, Patient Safety Officer
Bristol Myers Squibb, United States -
E. Stewart Geary, MD MD, Global Safety Officer
Eisai Co., Ltd., Japan -
Elizabeth E. Garrard, PHARMD Executive Vice President, Global Safety Operations
Clinipace Worldwide, United States -
Lisa Melanie Harinstein, PHARMD Team Leader, Division of Pharmacovigilance, FDA
FDA, United States -
Stephen Knowles, MD, MRCP Chief Medical Officer
Halozyme Therapeutics, United States -
Robert L. Levin, MD Lead Medical Officer for Pharmacovigilance Strategy
FDA, United States -
Michael Richardson, MD, FFPM, FRCP Senior Vice President, WorldWide Patient Safety
Bristol-Myers Squibb, United Kingdom -
Annette Stemhagen, DrPH, PHD, FISPE Chief Science Officer
UBC, United States -
Mick Foy Director of Delivery
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
